Current developments and future directions in androgen receptor targets using nano-based therapeutics for the management of cancer.

Nanoformulated androgen receptor (AR) antagonists constitute a cutting-edge advancement in the treatment of AR-driven cancers by significantly enhancing the precision and effectiveness of therapy. These nanoparticle-based formulations are uniquely de…

Preview only. Read the full abstract at the source